In conclusion, chronic PDTC administration reduced the progression of kidney enlargement, cyst volume, and proteinuria, but did not alter renal function, interstitial injury or NF‐κB activation in a nongenetically orthologous model of PKD. This evidence concerns the gene NFKB1 and cyst.